Ex vivo flow cytometry method and device
US9279813B2 · kind B2 · utility
4Cited by
57References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2014 |
| Grant date | Mar 8, 2016 |
| Priority date | — |
| Expiry date | Mar 18, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2458/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to a method for diagnosing a disease state mediated by pathogenic cells. The method comprises the steps of combining with an ex vivo patient sample a composition comprising a conjugate or complex of the general formulaAb-Xwherein the group Ab comprises a ligand that binds to the pathogenic cells and the group X comprises an imaging agent, and detecting the pathogenic cells that express a receptor for the ligand using flow cytometry.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.